Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kwon

Showing results (461-470 of 518) with videos related to

Pageof 52
Sort By:
BMC Cancer|November 28, 2022
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatmentC Martínez-Laperche, L Sanz-Villanueva, F J Díaz Crespo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 6, 2024
The extracellular matrix differentially directs myoblast motility and differentiation in distinct forms of muscular dystrophy: Dystrophic matrices alter myoblast motilityAshlee M Long, Jason M Kwon, GaHyun Lee, et al.
The Korean Journal of Internal Medicine|February 22, 2002
Total occlusion of left main coronary artery by dilated main pulmonary artery in a patient with severe pulmonary hypertensionJ Lee, H M Kwon, B K Hong, et al.
BMC Cancer|September 14, 2022
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatmentC Martínez-Laperche, L Sanz-Villanueva, F J Díaz Crespo, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
World Journal of Pediatrics : WJP|March 25, 2019
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophyQing Ke, Zheng-Yan Zhao, Jerry R Mendell, et al.
Neurology|July 27, 2005
A clinical rating scale for Batten disease: reliable and relevant for clinical trialsF J Marshall, E A de Blieck, J W Mink, et al.
Placenta|January 9, 2014
Increased NFAT5 expression stimulates transcription of Hsp70 in preeclamptic placentasJ K Park, T G Kang, M Y Kang, et al.
Bone Marrow Transplantation|April 10, 2007
New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survivalS T Kim, C W Jung, J Lee, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Pageof 52

Showing results (461-470 of 518) with videos related to

Sort By:
Pageof 52
BMC Cancer|November 28, 2022
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatmentC Martínez-Laperche, L Sanz-Villanueva, F J Díaz Crespo, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|April 6, 2024
The extracellular matrix differentially directs myoblast motility and differentiation in distinct forms of muscular dystrophy: Dystrophic matrices alter myoblast motilityAshlee M Long, Jason M Kwon, GaHyun Lee, et al.
The Korean Journal of Internal Medicine|February 22, 2002
Total occlusion of left main coronary artery by dilated main pulmonary artery in a patient with severe pulmonary hypertensionJ Lee, H M Kwon, B K Hong, et al.
BMC Cancer|September 14, 2022
EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatmentC Martínez-Laperche, L Sanz-Villanueva, F J Díaz Crespo, et al.
The Journal of Urology|November 22, 2011
Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug developmentNoah M Hahn, Patty L Bonney, Deepika Dhawan, et al.
World Journal of Pediatrics : WJP|March 25, 2019
Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophyQing Ke, Zheng-Yan Zhao, Jerry R Mendell, et al.
Neurology|July 27, 2005
A clinical rating scale for Batten disease: reliable and relevant for clinical trialsF J Marshall, E A de Blieck, J W Mink, et al.
Placenta|January 9, 2014
Increased NFAT5 expression stimulates transcription of Hsp70 in preeclamptic placentasJ K Park, T G Kang, M Y Kang, et al.
Bone Marrow Transplantation|April 10, 2007
New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survivalS T Kim, C W Jung, J Lee, et al.
BMC Cancer|August 13, 2008
Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancerLiesel M FitzGerald, Ilir Agalliu, Karynn Johnson, et al.
Pageof 52